Authors
Loading...
Genetic analysis reveals elevated circulating MCP-1 increases stroke risk in predisposed individuals, suggesting targeting inflammatory chemokine pathways could reduce stroke incidence.
Georgakis et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: